SPONSOR
University of Zurich
Total Trials
13
Recruiting
13
Phases
Phase 1
Conditions studied: Primary Immune Deficiency DisorderParkinson DiseaseMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific AntibodyGeriatric HematologyFinger InjuriesTendon Injury - HandHead and Neck CancersPregnancy
University of Zurich is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Primary Immune Deficiency Disorder, Parkinson Disease, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Zurich
How many clinical trials has University of Zurich sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University of Zurich, of which 13 are actively recruiting participants. These trials cover conditions including Primary Immune Deficiency Disorder, Parkinson Disease, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Zurich research focus on?
University of Zurich clinical trials span Primary Immune Deficiency Disorder, Parkinson Disease, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Zurich clinical trial?
To participate in a University of Zurich trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Zurich trials with current recruitment status updated daily.
Clinical Trials by University of Zurich
NCT03422614
Recruiting
Pathophysiology of Inborn Immunodeficiencies
Primary Immune Deficiency Disorder
NCT07082595
Recruiting
Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study
Parkinson Disease
NCT07309497
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
NCT04312412
Recruiting
Outcome of the Treatment of Flexor Tendon Injuries
Finger Injuries
NCT06870799
Recruiting
Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy
Head and Neck Cancers
NCT07587632
Recruiting
Natural Cervical Ripening to Prevent Pharmacological Induction of Labor - a Pilot Study.
Pregnancy
NCT04672551
Recruiting
EMDR Treatment in PTSD Following Cardiac Events
Posttraumatic Stress Disorder
NCT06043518
Recruiting
CNS Changes Following Upper Limb Loss
Amputation, Congenital
NCT05594368 Phase 1
Recruiting
Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial
Ventricular Tachycardia
NCT04668261
Recruiting
Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients
Brain Blood Flow Impairment
NCT07237087
Recruiting
Masseter Muscle Stiffness After Heat Application and Percussion Therapy
Healthy Participants
NCT02170155
Recruiting
MRI-changes in Morphometry and Cerebro Spinale Fluid (CSF) Flow in Spinal Cord Disorders
Spinal Injury
NCT05565326
Recruiting
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
Glioblastoma Multiforme
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology